...
首页> 外文期刊>Diabetes >Kir6.2 Mutations Associated With Neonatal Diabetes Reduce Expression of ATP-Sensitive K+ channels: Implications in Disease Mechanism and Sulfonylurea Therapy.
【24h】

Kir6.2 Mutations Associated With Neonatal Diabetes Reduce Expression of ATP-Sensitive K+ channels: Implications in Disease Mechanism and Sulfonylurea Therapy.

机译:与新生儿糖尿病相关的Kir6.2突变可降低ATP敏感性K +通道的表达:在疾病机理和磺酰脲疗法中的意义。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Heterozygous missense mutations in the pore-forming subunit Kir6.2 of ATP-sensitive K(+) channels (K(ATP) channels) have recently been shown to cause permanent neonatal diabetes mellitus (PNDM). Functional studies demonstrated that PNDM mutations reduce K(ATP) channel sensitivity to ATP inhibition, resulting in gain of channel function. However, the impact of these mutations on channel expression has not been examined. Here, we show that PNDM mutations, including Q52R, V59G, V59M, R201C, R201H, and I296L, not only reduce channel ATP sensitivity but also impair channel expression at the cell surface to varying degrees. By tagging the PNDM Kir6.2 mutant V59G or R201H with an additional mutation, N160D, that confers voltage-dependent polyamine block of K(ATP) channels, we demonstrate that in simulated heterozygous state, all surface channels are either wild-type or heteromeric channels containing both wild-type and mutant Kir6.2 subunits. Comparison of the various PNDM mutations in their effects on channel nucleotide sensitivity and expression, as well as disease phenotype, suggests that both channel-gating defect and expression level may play a role in determining disease severity. Interestingly, sulfonylureas significantly increase surface expression of certain PNDM mutants, suggesting that the efficacy of sulfonylurea therapy may be compromised by the effect of these drugs on channel expression.
机译:ATP敏感的K(+)通道(K(ATP)通道)的孔形成亚基Kir6.2的杂合错义突变最近已显示会导致永久性新生儿糖尿病(PNDM)。功能研究表明,PNDM突变可降低K(ATP)通道对ATP抑制的敏感性,从而获得通道功能。但是,尚未检查这些突变对通道表达的影响。在这里,我们显示PNDM突变(包括Q52R,V59G,V59M,R201C,R201H和I296L)不仅降低通道ATP敏感性,而且在不同程度上损害细胞表面的通道表达。通过标记具有附加突变N160D的PNDM Kir6.2突变体V59G或R201H,赋予K(ATP)通道电压依赖性多胺嵌段,我们证明了在模拟的杂合状态下,所有表面通道均为野生型或异源含有野生型和突变型Kir6.2亚基的通道。比较各种PNDM突变对通道核苷酸敏感性和表达以及疾病表型的影响,表明通道门控缺陷和表达水平均可能在确定疾病严重程度中起作用。有趣的是,磺酰脲类显着增加了某些PNDM突变体的表面表达,表明磺酰脲类疗法的疗效可能会受到这些药物对通道表达的影响而降低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号